Consistent with our data, IFNγ knockout mice are highly susceptible to disseminated C. albicans infection, and recombinant IFNγ treatment is reported to protect them against systemic candidiasis (Balish et al, 1998; Kullberg et al, 1993; Shalaby et al, 1985). This evidence concerns the gene IFNG and candidiasis.